Treatment with the glutamate modulator riluzole prevents early life stress-induced cognitive deficits and impairments in synaptic plasticity in APPswe/PS1dE9 mice
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Environmental factors like stress affect age-related cognitive deficits and promote Alzheimer's disease (AD)-related pathology in mice. Excess glutamate has been proposed as a possible mediator underlying these effects in the hippocampus, a vulnerable brain region implicated in learning and memory. METHODS: Here, we examined a) whether stress applied during a sensitive developmental period early in life affects later synaptic plasticity, learning and memory and plaque load in the APPswe/PS1dE9 mouse model for Alzheimer's disease and b) whether these effects could be rescued using long-term treatment with the glutamate modulator riluzole. RESULTS: Our results demonstrate that ELS impairs synaptic plasticity in 6-month-old mice and increases plaque load in 12-month-old APPswe/PS1dE9 mice, while impairing flexible spatial learning in the Barnes maze at this age. Notably, spatial learning correlated well with hippocampal expression of the transporter EAAT2, which is important for extracellular glutamate uptake. The changes in LTP, plaque load and cognition after ELS were all prevented by riluzole treatment that started from post-weaning. CONCLUSION: These results suggest that normalising glutamate signalling may be a viable therapeutic strategy for treating vulnerable individuals at risk of developing stress-aggravated AD, particularly in relation to adverse early life experiences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125 · cited 1×
“While familial forms of AD are linked to rare genetic mutations (Querfurth and LaFerla, 2010; Scheltens et al., 2016), the cause of sporadic AD remains elusive.”
BackgroundBaumgart, M., Snyder, H. M., Carrillo, M. C., Fazio, S., Kim, H., & Johns, H. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.016 · Cited by 1,660 · cited 1×
“Various recent lines of evidence suggest that environmental factors play a role in AD risk (Baumgart et al., 2015; Herbert and Lucassen, 2016; Matthews et al., 2016; Xu et al., 2015).”
BackgroundSynaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644 · cited 3×
“mate outside the synaptic cleft, preventing excess glutamate from binding to extra-synaptic NMDA receptors, reducing synaptic efficiency and inducing LTD and excitotoxicity (Hardingham and Bading, 2010), and has been implicated in aging and various neurodegenerative diseases, including AD (Hardingham and Bading, 2010;…”
BackgroundAPP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 2×
“…AD have implicated glutamatergic N-methyl-D-aspartate (NMDA) receptors in AD and reveal that glutamatergic synapses are particularly affected (Haass and Selkoe, 2007; Kamenetz et al., 2003; Kessels et al., 2013; Rowan et al., 2003; Townsend et al., 2006; Turner et al., 2003; Walsh et al., 2002).”
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 1×
“This is thought to occur through an excessive activation of extra-synaptic NMDA receptors (Li et al., 2011, 2009), and a decrease in the expression of synaptic NMDA receptors (Snyder et al., 2005).”
BackgroundControl of memory formation through regulated expression of a CaMKII transgene
Mayford, M., Bach, M. E., Huang, Y.-Y., Wang, L., Hawkins, R. D., & Kandel, E. R. (1996) · Science · doi:10.1126/science.274.5293.1678 · Cited by 1,550 · cited 1×
“When recordings were stable, afferent fibres were stimulated at 10 Hz for 90 s (Mayford et al., 1996; Wiegert et al., 2006).”
MethodSperling, R. A., LaViolette, P. S., O'Keefe, K., O'Brien, J., Rentz, D. M., Pihlajamaki, M., Marshall, G., Hyman, B. T., Selkoe, D. J., Hedden, T., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.07.003 · Cited by 1,027
Synaptic AMPA receptor plasticity and behavior
Kessels, H. W., & Malinow, R. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.015 · Cited by 993 · cited 1×
“LTP is an important cellular model for learning and memory (Kessels and Malinow, 2009; Malinow and Malenka, 2002), and functional brain abnormalities have been observed in humans decades before the development of other symptoms (Reiman et al., 2004; Sperling et al., 2009).”
BackgroundFunctional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977 · cited 2×
“Synaptic dysfunction is an important mechanism implicated in AD-related cognitive deficits (Selkoe, 2002; DeKosky and Scheff, 1990) and presenting as one of the first symptoms of AD (Sperling et al., 2009; Reiman et al., 2004).”
BackgroundEarly-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600948103 · Cited by 701 · cited 1×
“In addition, LTP was impaired in APPswe/PS1dE9 mice which is in line with earlier studies showing impairments in synaptic plasticity in (transgenic) mouse models of AD (Jacobsen et al., 2006; Rowan et al., 2003).”
ResultTownsend, M., Shankar, G. M., Mehta, T., Walsh, D. M., & Selkoe, D. J. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.103754 · Cited by 619
Meta-analysis of modifiable risk factors for Alzheimer's disease
Xu, W., Tan, L., Wang, H.-F., Jiang, T., Tan, M.-S., Tan, L., Zhao, Q.-F., Li, J.-Q., Wang, J., & Yu, J.-T. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310548 · Cited by 573
A Novel Mouse Model for Acute and Long-Lasting Consequences of Early Life Stress
Rice, C. J., Sandman, C. A., Lenjavi, M. R., & Baram, T. Z. (2008) · Endocrinology · doi:10.1210/en.2008-0633 · Cited by 521 · cited 2×
“Pregnant females were housed individually in a standard cage covered with a filter top and monitored daily for the birth of pups (Arp et al., 2016; Lesuis et al., 2018, 2016; Rice et al., 2008).”
MethodMechanisms of late-onset cognitive decline after early-life stress
Brunson, K. L., Kramár, E., Lin, B., Chen, Y., Colgin, L. L., Yanagihara, T. K., Lynch, G., & Baram, T. Z. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2281-05.2005 · Cited by 479
Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease
Masliah, E., Hansen, L., Alford, M., Deteresa, R., & Mallory, M. (1996) · Annals of Neurology · doi:10.1002/ana.410400512 · Cited by 476 · cited 2×
“…expression of glutamate transporters, including EAAT2, is decreased after early life stress (Odeon et al., 2015), in aging (Brothers et al., 2013; Potier et al., 2010) as well as in AD (Jacob et al., 2007; Masliah et al., 1996) and has been associated with neurodegeneration (Masliah et al., 1996).”
BackgroundRusakov, D. A., & Kullmann, D. M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03158.1998 · Cited by 438
A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II
Matthews, F. E., Stephan, B. C. M., Robinson, L., Jagger, C., Barnes, L. E., Arthur, A., Brayne, C., Cognitive Function and Ageing Studies (CFAS) Collaboration, Comas-Herrera, A., Wittenberg, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11398 · Cited by 426 · cited 1×
“Various recent lines of evidence suggest that environmental factors play a role in AD risk (Baumgart et al., 2015; Herbert and Lucassen, 2016; Matthews et al., 2016; Xu et al., 2015).”
BackgroundBellingham, M. C. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00116.x · Cited by 388 · cited 2×
“However, in addition to regulating glutamate levels, the drug has additional pharmacological effects such as inhibiting Na + channels (Bellingham, 2011).”
BackgroundTelomeres and early-life stress: an overview
Price, L. H., Kao, H.-T., Burgers, D. E., Carpenter, L. L., & Tyrka, A. R. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.025 · Cited by 339 · cited 1×
“Such ELS-induced accelerations of cognitive decline are often accompanied by (neuro) biological changes of aging, such as a reduced telomere length (Price et al., 2013), reductions in adult hippocampal neurogenesis (Bath et al., 2016; Lucassen et al., 2015; Naninck et al., 2015), and enhanced…”
BackgroundJacob, C. P., Koutsilieri, E., Bartl, J., Neuen-Jacob, E., Arzberger, T., Zander, N., Ravid, R., Roggendorf, W., Riederer, P., & Grünblatt, E. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11113 · Cited by 317
LTP Promotes a Selective Long-Term Stabilization and Clustering of Dendritic Spines
De Roo, M., Klauser, P., & Muller, D. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060219 · Cited by 223
Bagot, R. C., van Hasselt, F. N., Champagne, D. L., Meaney, M. J., Krugers, H. J., & Joëls, M. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.03.004 · Cited by 216 · cited 1×
“Field excitatory synaptic potentials (fEPSPs) were recorded as described previously (Bagot et al., 2009; Pu et al., 2007; Wiegert et al., 2006).”
MethodSelf-citationImaging hippocampal function across the human life span: Is memory decline normal or not?
Small, S. A., Tsai, W. Y., DeLaPaz, R., Mayeux, R., & Stern, Y. (2002) · Annals of Neurology · doi:10.1002/ana.10105 · Cited by 205 · cited 1×
“…(AD) is a common age-related neurodegenerative disorder characterised by progressive cognitive decline (Selkoe and Schenk, 2003) that is, in view of current human life expectancy (Jagust, 2013; Prince et al., 2013; Small et al., 2002), expected to increase in the future (Brookmeyer et al., 2007).”
BackgroundRiluzole in the Treatment of Mood and Anxiety Disorders
Pittenger, C., Coric, V., Banasr, M., Bloch, M., Krystal, J. H., & Sanacora, G. (2008) · CNS Drugs · doi:10.2165/00023210-200822090-00004 · Cited by 177 · cited 3×
“…mechanism via which the effect of riluzole may rescue both these impairments, could be through regulating EAAT2 expression (Brothers et al., 2013; Pereira et al., 2017; Pittenger et al., 2008), which is relevant for maintaining proper synaptic glutamate levels (Tzingounis and Wadiche, 2007).”
BackgroundLucassen, P. J., Oomen, C. A., Naninck, E. F. G., Fitzsimons, C. P., van Dam, A.-M., Czeh, B., & Korosi, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021303 · Cited by 166
Wiegert, O., Joëls, M., & Krugers, H. (2006) · Learning & Memory · doi:10.1101/lm.87706 · Cited by 162 · cited 2×
“When recordings were stable, afferent fibres were stimulated at 10 Hz for 90 s (Mayford et al., 1996; Wiegert et al., 2006).”
MethodSelf-citationHerbert, J., & Lucassen, P. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.12.001 · Cited by 150
Self-citationHoeijmakers, L., Ruigrok, S. R., Amelianchik, A., Ivan, D., van Dam, A.-M., Lucassen, P. J., & Korosi, A. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.12.023 · Cited by 138 · cited 2×
“In addition, it has been shown that ELS aggravates AD-related neuropathology, including increased soluble Aβ levels, increased plaque load, and impaired cognitive performance (Hoeijmakers et al., 2016; Lesuis et al., 2018, 2016).”
BackgroundSelf-citationInteractions Between Age, Stress and Insulin on Cognition: Implications for Alzheimer's Disease
Solas, M., Aisa, B., Mugueta, M. C., Del Río, J., Tordera, R. M., & Ramírez, M. J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.13 · Cited by 124
Age and Alzheimer’s disease gene expression profiles reversed by the glutamate modulator riluzole
Pereira, A. C., Gray, J. D., Kogan, J. F., Davidson, R. L., Rubin, T. G., Okamoto, M., Morrison, J. H., & McEwen, B. S. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.33 · Cited by 116 · cited 7×
“…mechanism via which the effect of riluzole may rescue both these impairments, could be through regulating EAAT2 expression (Brothers et al., 2013; Pereira et al., 2017; Pittenger et al., 2008), which is relevant for maintaining proper synaptic glutamate levels (Tzingounis and Wadiche, 2007).”
BackgroundMethodInfluentialPereira, A. C., Lambert, H. K., Grossman, Y. S., Dumitriu, D., Waldman, R., Jannetty, S. K., Calakos, K., Janssen, W. G., McEwen, B. S., & Morrison, J. H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421285111 · Cited by 116 · cited 2×
“In addition, others have previously observed increased spine clustering in the same area in riluzole-treated rats, which also correlated with cognitive performance (Pereira et al., 2014), suggesting a potential mechanism by which riluzole can increase cognitive performance.”
BackgroundEffects of early-life stress on cognitive function and hippocampal structure in female rodents.
Loi, M., Mossink, J. C. L., Meerhoff, G. F., Den Blaauwen, J. L., Lucassen, P. J., & Joëls, M. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.024 · Cited by 109 · cited 1×
“Since effects of ELS are particularly sex-specific (Loi et al., 2017; Naninck et al., 2015), all experiments were further conducted with male mice.”
BackgroundSelf-citationMarlatt, M. W., Potter, M. C., Bayer, T. A., van Praag, H., & Lucassen, P. J. (2013) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2012_237 · Cited by 92
Self-citationLesuis, S. L., Weggen, S., Baches, S., Lucassen, P. J., & Krugers, H. J. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0101-2 · Cited by 85 · cited 6×
“Previous studies have reported that early life stress can alter flexible spatial learning, synaptic plasticity and amyloid levels in 12-month-old APPswe/PS1dE9 mice (Lesuis et al., 2018).”
InfluentialSelf-citationYam, K. Y., Naninck, E. F. G., Abbink, M. R., la Fleur, S. E., Schipper, L., van den Beukel, J. C., Grefhorst, A., Oosting, A., van der Beek, E. M., Lucassen, P. J., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.12.012 · Cited by 78
Self-citationChristensen, D. Z., Bayer, T. A., & Wirths, O. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.014 · Cited by 47 · cited 1×
“Measurements were performed for the percentage area covered by DAB staining (Christensen et al., 2009; Marlatt et al., 2013).”
Method
Cited by
The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders
Sanacora, G., Yan, Z., & Popoli, M. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00540-x · Cited by 197
Hu, P., Maita, I., Phan, M. L., Gu, E., Kwok, C., Dieterich, A., Gergues, M. M., Yohn, C. N., Wang, Y., Zhou, J.-N., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01070-3 · Cited by 49
Self-citationGlucocorticoids, synaptic plasticity and Alzheimer’s disease
Klyubin, I., Ondrejcak, T., Hu, N.-W., & Rowan, M. J. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100365 · Cited by 16
Metadata
- Authors
- Lesuis, S. L., Kaplick, P. M., Lucassen, P. J., & Krugers, H. J.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 150
- Pages
- 175-183
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2915389159
- Cited by
- 41
- References
- 36
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.